Daratumumab — Dosing in CKD & Dialysis

Daratumumab (Monoclonal Antibody): renal dosing adjustments, dialyzability (Not studied in the label (no statement on removal by dialysis; its renal analysis covers CLcr 15 to 89 mL/min only); IgG1 kappa monoclonal antibody of about 148 kDa (Darzalex label 11, 12.3). Level estimated from molecule si

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.